Articles tagged with

NICE decision on Alzheimer’s Drugs to Benefit Thousands

The Alzheimer’s Research Trust has welcomed the NICE decision to extend the availability of Alzheimer’s drugs. Three drugs currently used for moderate Alzheimer’s will now be available to treat mild stages of the disease as well. As part of the latest guidance NICE used a new economic model and found the drugs to be cost-effective. [...]

Tags: , ,

New Treatment Target for Alzheimer’s

US scientists have found that boosting levels of a protein, EphB2, improves nerve cell function and memory in mice with Alzheimer’s. Their findings, published in Nature, highlight potential new treatment targets. EphB2 amounts are abnormally low in an area of the brain responsible for memory in mice with Alzheimer’s, as well as people with the [...]

Tags: ,

Old Masters Inspire Alzheimer’s Groups

People with dementia have been encouraged to engage with art through a joint project by the National Gallery and Alzheimer’s Society. The project was organised and funded by Credit Suisse who partner with the National Gallery, and support Alzheimer’s Society through the UK Charity of the Year 2010 programme. The innovative project, part of the [...]

Tags: , ,

Journeys Into Alzheimers

Once an ignored, overlooked condition, Alzheimer’s and other forms of dementia are in the spotlight like never before, thanks in part to a growing number of books on the subject. But are these books any more than a new form of ‘mis lit’ and can they really help make a difference? In retrospect, there was [...]

Tags: , , , , ,

B Vitamins Linked with Reduced Alzheimer’s Risk

B vitamins have again been linked to a reduced risk of Alzheimer’s, following a seven-year observational study by the Karolinska Institute in Sweden. The latest findings, which focus on vitamin B12, add to recent high-profile studies into the protective effects of the vitamins. The research, published in the October issue of Neurology, adds further to [...]

Tags: ,

Alzheimer’s Drugs Proposal Welcomed

New proposals recommending three drugs, currently used for moderate Alzheimer’s, to be expanded to treat mild stages of the disease, have been welcomed by the Alzheimer’s Research Trust (ART). The draft guidelines from the National Institute for Health and Clinical Excellence (NICE) also recommend use of a further drug, memantine, to treat severe Alzheimer’s and [...]

Tags: